Acute heart failure: ECMO Cardiology & Vascular Medicine 2012

Similar documents
Extra Corporeal Life Support for Acute Heart failure

Management of Cardiogenic Shock. Dr Stephen Pettit, Consultant Cardiologist

Cardiogenic Shock in Acute MI

AllinaHealthSystem 1

Echo assessment of patients with an ECMO device

ECMO as a bridge to durable LVAD therapy. Jonathan Haft, MD Department of Cardiac Surgery University of Michigan

DECLARATION OF CONFLICT OF INTEREST

Understanding the Pediatric Ventricular Assist Device

Guideline compliance, utilization trends

MANAGEMENT OF CARDIOGENIC SHOCK

The Role of Mechanical Circulatory Support in Cardiogenic Shock: When to Utilize

To ECMO Or Not To ECMO Challenges of venous arterial ECMO. Dr Emily Granger St Vincent s Hospital Darlinghurst NSW

Mechanical Circulatory Support (MCS): What Every Pharmacist Needs to Know!

Mechanical Cardiac Support in Acute Heart Failure. Michael Felker, MD, MHS Associate Professor of Medicine Director of Heart Failure Research

Management of Acute Shock and Right Ventricular Failure

Andrew Civitello MD, FACC

University of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CICU Rotation Goals and Objectives

Mechanical circulatory support in cardiogenic shock The Cardiologist s view ACCA Masterclass 2017

Planned, Short-Term RVAD During Durable LVAD Implant: Indications and Management

Introduction to Acute Mechanical Circulatory Support

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition

A Validated Practical Risk Score to Predict the Need for RVAD after Continuous-flow LVAD

Innovative ECMO Configurations in Adults

PUMP FAILURE COMPLICATING AMI: ISCHAEMIC VSR

A case of post myocardial infarction ventricular septal rupture CHRISTOFOROS KOBOROZOS, MD

Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )

Which mechanical assistance for cardiogenic shock?

เอกราช อร ยะช ยพาณ ชย

EACTS Adult Cardiac Database

Jennifer A. Brown The Cleveland Clinic School of Perfusion Cleveland, Ohio

EXTRA CORPOREAL MEMBRANE OXYGENATION

Rationale for Prophylactic Support During Percutaneous Coronary Intervention

Ventricular Assisting Devices in the Cathlab. Unrestricted

Percutaneous Mechanical Circulatory Support Devices

CENTRAL ECMO WHEN AND HOW? RANJIT JOHN, MD UNIVERSITY OF MINESOTA

Update on Mechanical Circulatory Support. AATS May 5, 2010 Toronto, ON Canada

Disclosures. Objectives 10/11/17. Short Term Mechanical Circulatory Support for Advanced Cardiogenic Shock. I have no disclosures to report

Ted Feldman, M.D., MSCAI FACC FESC

LV Distension and ECLS Lungs

Antonio Colombo. Centro Cuore Columbus and S. Raffaele Scientific Institute, Milan, Italy. Miracor Symposium. Speaker: 15. Parigi: May 16-19, 2017

Implantable Ventricular Assist Devices and Total Artificial Hearts. Policy Specific Section: June 13, 1997 March 29, 2013

Percutaneous Mechanical Circulatory Support for Cardiogenic Shock. 24 th Annual San Diego Heart Failure Symposium Ryan R Reeves, MD FSCAI

Bridging With Percutaneous Devices: Tandem Heart and Impella

Device Therapy for Heart Failure

IABP SHOCK II trial:

ORIGINAL ARTICLE. Alexander M. Bernhardt a, *, Theo M.M.H. De By b, Hermann Reichenspurner a and Tobias Deuse a. Abstract INTRODUCTION

Cath Lab Essentials : LV Assist Devices for Hemodynamic Support (IABP, Impella, Tandem Heart, ECMO)

Adult Extracorporeal Life Support (ECLS)

Circulatory Support: From IABP to LVAD

Low cardiac output & Mechanical Support นายแพทย อรรถภ ม ส ศ ภอรรถ ศ ลยศาสตร ห วใจและทรวงอก โรงพยาบาล ราชว ถ

Case scenario V AV ECMO. Dr Pranay Oza

Ray Matthews MD Professor of Clinical Medicine Chief of Cardiology University of Southern California

IABP to prevent pulmonary edema under VA-ECMO

Cardiogenic Shock. Carlos Cafri,, MD

How to do Primary Angioplasty. - Patients with Cardiogenic Shock

Complications of Acute Myocardial Infarction

Assist Devices in STEMI- Intra-aortic Balloon Pump

Cardiac surgery - CAD

VENTRICULAR ASSIST DEVICES AND TOTAL ARTIFICIAL HEARTS

Modern Left Ventricular Assist Devices (LVAD) : An Intro, Complications, and Emergencies

Case - Advanced HF and Shock (INTERMACS 1)

CABG for ischemic cardiomyopathy, post myocardial infarction and cardiogenic shock

Left Ventricular Assist Devices (LVADs): Overview and Future Directions

Extracorporeal Membrane Oxygenation (ECMO)

ECMO as a Bridge to Heart Transplant in the Era of LVAD s.

Intra-operative Echocardiography: When to Go Back on Pump

Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3 (MOMENTUM 3) Long Term Outcomes

3/1/2017. Heart Failure is a major driver of morbidity and mortality in the US 1-7

Cardiogenic Shock Protocol

SARASOTA MEMORIAL HOSPITAL NURSING DEPARTMENT POLICY

Percutaneous mechanical circulatory support for treatment and prevention of hemodynamic instability Engström, A.E.

Recognizing the Need to Support A Failing Right Ventricular Role of Mechanical Support

Short and long term mechanical circulatory support: Management in intensive care. Dr Ana Hurtado Consultant Intensivist Harefield Hospital, UK

Mechanics of Cath Lab Support Devices

8th Emirates Cardiac Society Congress in collaboration with ACC Middle East Conference Dubai: October Acute Coronary Syndromes

University of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives

Right Heart Failure in LVAD patients: Prevention and Management.

Initial experience with Imacor htee-guided management of patients following transplant and mechanical circulatory support.

Counterpulsation. John N. Nanas, MD, PhD. Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece

Policy Specific Section: May 16, 1984 April 9, 2014

Complications of VAD therapy - RV failure

Mechanics of Cath Lab Support Devices

CHF ICU to community. Disclosure slide CHF. Diagnosis. Diagnosis. Diagnostic modalties Therapeutic modalities. Talks. Advisory boards.

Right Ventricular Failure: Prediction, Prevention and Treatment

Acute Circulatory Support Should We or Shouldn t We?

Yes No Unknown. Major Infection Information

Mechanical Cardiac Support and Cardiac Transplant: The Role for Echocardiography

Ventricular Assist Device: Are Early Interventions Superior? Hamang Patel, MD Section of Cardiomyopathy & Heart Transplantation

New Horizons in Cardiogenic Shock. Timothy D. Henry, MD Director of Cardiology Cedars-Sinai Heart Institute

4. Which survey program does your facility use to get your program designated by the state?

The Case for Multivessel Revascularization in Shock

ST-Elevation Myocardial Infarction & Cardiogenic Shock. - What Should We Do?

Hemodynamic Monitoring and Circulatory Assist Devices

Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.

AATS/Cardiothoracic Critical Care Symposium

Implantable Ventricular Assist Devices and Total Artificial Hearts

Medical Management of Acute Heart Failure

ECMO Primer A View to the Future

In the setting of liver failure & transplantation?

Heart Failure Medical and Surgical Treatment

Transcription:

Acute heart failure: ECMO Cardiology & Vascular Medicine 2012 Lucia Jewbali cardiologist-intensivist

14 beds/8 ICU beds Acute coronary syndromes Heart failure/ Cardiogenic shock Post cardiotomy Heart transplantation IABP/ECMO/LVAD Post-procedure observation percutananeous valves

ECMO Extra Corporeal Membrane Oxygenation

Q 1 : ECMO (extracorporeal membrane oxygenation) 1. ECMO is available in my center and I have clinical experience with managing ECMO patients 2. ECMO is available in my center but I am not directly involved in the program 3. I have heard about ECMO; I am not familiar with this therapy and its clinical applicability

Case Female 59 years old No medical history Referred from regional hospital with sub-acute myocardial infarction complicated by cardiogenic shock and third-degree AV block

ECG

Case PCI left anterior descending artery: trombus aspiration and stenting (Promus DES 3.0x20 mm). RCA occluded with collateral flow from the left anterior descending artery. Stenotic lesion ramus circumflexus Treated with temporary pacing lead, intra-aortic balloon pump and high dose inotropics Transferred to ward after 1 week; ACE-inhibitor, diuretics and eplenerone

Case CK peak 5100 U/l, CK-MB peak 250 µg/l Weaned from IABP, inotropics and mechanical ventilation Echocardiography (TTE): Poor LV function Transferred to ward after 1 week; ACE-inhibitor, diuretics and eplenerone

Case DDD-ICD implanted Several shocks >> ventricular arrhythmias Medication:ACE-inhibitor, Eplenerone, beta-blocker, diuretics, statines, ASA, prasugrel

Reflections: what to do? 1. detection ischemia 2. increase dose beta blocker and/or add amiodarone 3. adjust ICD settings

Case MIBI scan: large defect apex, septum, anterior- and inferior wall, no ischemia FDG-PET scan: no hibernation myocard Increased beta blocker dosage Amiodarone added ICD settings adjusted

Case Despite all this : electrical storm with hemodynamic instability Admitted into ICCU Amiodarone iv, Lidocaine iv, optimized electrolytes, anxiolytica, vasopressor, inotropics Remained unstable eventually sedated, intubated and put on mechanical ventilation

Case Less arrhythmias, not event free Hypotensive (systolic blood pressure 90 mmhg) despite vasopressors and low dose inotropics Oliguria (< 35 ml/h), creatinin 144 µmol/l Signs of tissue hypoperfusion (cold peripheries) Lactate 1.7 mmol/l

Q 2: what would be the next step? 1. Further adjustments of inotropics and anti-arrhytmics 2. place an intra-aortic balloon pump 3. no adjustments

Case - adjustments in medication did not improve hemodynamics - intra-aortic balloonpump was placed

Goal of treatment reached?

Q 4 : What do the guidelines say? Which are immediate goals of treatment in acute heart failure? 1. restore oxygenation, improve hemodynamics and organ perfusion 2. limit cardiac and renal damage 3. prevent thrombo-emboli and minimize ICU length of stay 4. all of the above

ESC guidelines acute and chronic heart failure Eur Heart J. 2012 May 19

How is the patient doing? - Arrhythmias - Sustained hypotension (systolic blood pressure < 90 mmhg) despite vasopressors and low dose inotropics - Oliguria (< 35 ml/h) - Signs of tissue hypoperfusion (cold peripheries)

Q 5: what do the guidelines say? In patients remaining severely hypoperfused despite inotropic therapy and with a potentially reversible cause short-term mechanical circulatory support: 1. is recommended (Class I) 2. should be considered (Class II a) 3. may be considered (Class II b) 4. is not recommended (Class III) 5. ECMO is not considered to be short-term mechanical support

ESC guidelines acute and chronic heart failure Eur Heart J. 2012 May 19

Mechanical circulatory support - intra-aortic ballonpump - Ventricular assist devices - percutaneous (Tandem Heart, Impella) - surgical: LVAD, RVAD, BIVAD (Centrimag, Biomedicus, Medos, Heartmate) - ECMO

ECMO is a modification of the cardiopulmonary bypass circuit which is used routinely in cardiac surgery It is used as temporary support, usually awaiting recovery of organs

Dynamics of ECMO

Indications for ECMO Divided into two type Cardiac Failure Respiratory Failure

Veno-arterial (VA) configuration Blood being drained from the venous system and returned to the arterial system Provides both cardiac and respiratory support Achieved by either peripheral or central cannulation

Central ECMO Cannulation

Peripheral ECMO Cannulation

Things to Think About Mechanical ventilation must be continued during ECMO support ECMO flow can be very volume dependent

Weaning of ECMO VA ECMO Depends on cardiac recovery Echo: improvement LV function Increasing blood pressure Return or increasing pulsatility on the arterial pressure waveform

Complications Falls into one of three major categories 1) Bleeding/Hemolysis 2) Mechanical failure 3) Neurologic events

Decision to place ECMO Several considerations must be weighed: Likelihood of organ recovery Advanced age Malignancy Graft vs. host disease Known severe brain injury Unwitnessed cardiac arrest or cardiac arrest of prolonged duration.

Q 5 : use of mechanical circulatory support In this patient ECMO can be used as a: 1. bridge to decision 2. bridge to transplant 3. bridge to recovery 4. destination therapy

ESC guidelines acute and chronic heart failure Eur Heart J. 2012 May 19

INTERMACS profiles of advanced heart failure. Stewart G C, Stevenson L W Circulation 2011;123:1559-1568 Copyright American Heart Association

Placement VA ECMO in cathlab

Angio

Case Bridged to LVAD/ 4 days on ECMO Discharged from hospital two months after initial admittance

Q 6 : survival following cardiac ECMO (adults) till hospital discharge 1. 54% 2. 44% 3. 34% 4. 24%

Cove and MacLaren Critical Care 2010, 14:235

Present clinical use of ECMO Post-cardiotomy Post-heart transplant Myocarditis PCI -assist Acute coronary syndrome with cardiogenic shock? Profound cardiac depression due to drug overdose or sepsis?